Core Insights - Tilray Brands Inc. (NASDAQ:TLRY) experienced a significant increase in share price, rising by 8.23% to $1.71, as investors adjusted their portfolios in anticipation of a decision from President Donald Trump regarding the legalization of cannabis and CBD products [1][3]. Group 1: Market Reaction - Investors are actively investing in cannabis product manufacturers, including Tilray Brands Inc., Canopy Growth, Cronos Group, and Aurora Cannabis, in light of a positive decision expected soon [2]. - The rise in Tilray's stock price reflects broader market optimism surrounding potential cannabis legalization, driven by Trump's recent promotion of cannabis and CBD for medical use [3]. Group 2: Policy Implications - Trump's social media video highlighted the potential benefits of CBD oil, suggesting it could transform senior healthcare and reduce medical costs in the U.S. by $64 billion, which has influenced investor sentiment [3].

We recently published 10 Stocks With 10-60% Upside. Tilray Brands Inc. (NASDAQ:TLRY) is one of the top performers on Monday. Tilray soared at an all-time high on Monday as investors took path from President Donald Trump’s promotion of the use of cannabis and cannabidiol (CBD) in the US. In intra-day trading, Tilray Brands Inc. (NASDAQ:TLRY) hit its highest price of $1.86 before trimming gains to finish the day just up by 60.87 percent at $1.85 apiece, as investors took Trump’s three-minute video post pro ...